Meme Kanserinde Adjuvan Radyoterapi

Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al. Breast cancer statistics 2024. CA: a cancer journal for clinicians. 2024;74(6):477-95.

Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181-5.

Knowlton CA, Blitzblau RC. Locally Advanced and Inflammatory Breast Cancer. Gunderson and Tepper’s Clinical Radiation Oncology: Elsevier; 2026. p. 1386-403. e5.

Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2024;22(5):331-57.

Trayes KP, Cokenakes SE. Breast cancer treatment. American family physician. 2021;104(2):171-8.

Loibl S, André F, Bachelot T, Barrios C, Bergh J, Burstein H, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2024;35(2):159-82.

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-16.

Group EBCTC. Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials. The Lancet. 2024;404(10461):1407-18.

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine. 2002;347(16):1227-32.

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England journal of medicine. 2002;347(16):1233-41.

Kolářová I, Melichar B, Sirák I, Vaňásek J, Petera J, Horáčková K, et al. The role of adjuvant radiotherapy in the treatment of breast cancer. Current Oncology. 2024;31(3):1207-20.

Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Practical radiation oncology. 2024;14(2):112-32.

Gunderson LL, Tepper JE. Clinical radiation oncology: Elsevier Health Sciences; 2015.

Cardoso MJ, de Boniface J, Dodwell D, Kaidar-Person O, Poortmans P, van Maaren MC. Which real indications remain for mastectomy? The Lancet Regional Health–Americas. 2024;33.

Kent C, Horton J, Blitzblau R, Koontz BF. Whose disease will recur after mastectomy for early stage, node-negative breast cancer? A systematic review. Clinical Breast Cancer. 2015;15(6):403-12.

McGale P, Correa C, Cutter D, Duane F, Ewertz M, Gray R, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 2014;383(9935):2127-35.

Overgaard M. pres: italics> et al.(1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med.337:949-55.

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Journal of the National Cancer Institute. 2005;97(2):116-26.

Johnson ME, Handorf EA, Martin JM, Hayes SB. Postmastectomy radiation therapy for T3N0: a SEER analysis. Cancer. 2014;120(22):3569-74.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. Jama. 2017;318(10):918-26.

Reimer T, Stachs A, Veselinovic K, Kühn T, Heil J, Polata S, et al. Axillary surgery in breast cancer—primary results of the INSEMA trial. New England Journal of Medicine. 2025;392(11):1051-64.

Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA oncology. 2023;9(11):1557-64.

Lim GH, Teo SY, Allen Jr JC, Chinthala JP, Leong LCH. Determining whether high nodal burden in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy. Journal of Breast Cancer. 2019;22(1):67.

Jimenez RB, Abdou Y, Anderson P, Barry P, Bradfield L, Bradley JA, et al. Postmastectomy radiation therapy: an ASTRO-ASCO-SSO clinical practice guideline. Journal of Clinical Oncology. 2025;43(30):3292-311.

Mamounas EP, White JR, Bandos H, Julian TB, Kahn AJ, Shaitelman SF, et al. NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC. American Society of Clinical Oncology; 2014.

Kim D, Kim JH, Kim IA, Chang JH, Shin KH. Impact of postmastectomy radiation therapy on breast cancer patients according to pathologic nodal status after modern neoadjuvant chemotherapy. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2023;55(2):592-602.

Group ST. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet. 2008;371(9618):1098-107.

Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, et al. Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. Journal of Clinical Oncology. 2020;38(28):3261-72.

Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet. 2020;395(10237):1613-26.

Vaidya J. Multicentricity and recurrence of breast cancer. Lancet. 1997.

Ganz PA, Cecchini RS, White JR, Vicini FA, Arthur DW, Rabinovitch RA, et al. Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery. JNCI: Journal of the National Cancer Institute. 2025;117(1):103-11.

Kirby AM, Finneran L, Griffin CL, Brunt AM, Cafferty FH, Alhasso A, et al. Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology. 2025;26(7):898-910.

Thorsen LB, Overgaard J, Matthiessen LW, Berg M, Stenbygaard L, Pedersen AN, et al. Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish breast cancer group internal mammary node study. Journal of Clinical Oncology. 2022;40(36):4198-206.

Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. New England Journal of Medicine. 2015;373(4):317-27.

Whelan T, Olivotto I, Ackerman I, Chapman J, Chua B, Nabid A, et al. NCIC CTG MA. 20: An intergroup trial of regional nodal irradiation in early breast cancer. Journal of clinical oncology. 2011;29(15_suppl):LBA1003-LBA.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, et al. Postmastectomy radiotherapy: an American society of clinical oncology, American society for radiation oncology, and society of surgical oncology focused guideline update. Journal of Clinical Oncology. 2016;34(36):4431-42.

Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois J-B, Datchary J, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. International Journal of Radiation Oncology* Biology* Physics. 2013;86(5):860-6.

MacDonald S, Pugh S, Paulus R, Chauhan C, Braunstein L, Freedman G, et al. Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (Radcomp) Consortium Trial: Health-Related Quality of Life Outcomes. International Journal of Radiation Oncology, Biology, Physics. 2025;123(4):1195.

Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. New England Journal of Medicine. 2013;368(11):987-98.

Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA oncology. 2015;1(7):918-30.

Lee SF, Wong HC, Robijns J, Ciocon SLB, Dos Reis PED, Sadeghi S, et al. Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques. Breast Cancer Research and Treatment. 2025;212(1):1-12.

Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World journal of clinical oncology. 2014;5(3):241.

Harris SR. Brachial plexopathy after breast cancer: A persistent late effect of radiotherapy. PM&R. 2024;16(1):85-91.

Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. International Journal of Radiation Oncology* Biology* Physics. 1979;5(2):257-61.

Yu T, Eom K-Y, Jang NY, Kim KS, Koo TR, Kwon J, et al. Objective measurement of cosmetic outcomes of breast conserving therapy using BCCT. core. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2016;48(2):491-8.

Group EBCTC. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet. 2011;378(9804):1707-16.

Fisher ER, Dignam J, Tan‐Chiu E, Costantino J, Fisher B, Paik S, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17: intraductal carcinoma. Cancer. 1999;86(3):429-38.

Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. The lancet oncology. 2011;12(1):21-9.

Wärnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. Journal of clinical oncology. 2014;32(32):3613-8.

Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. Journal of clinical oncology. 2013;31(19):2382-7.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. New England Journal of Medicine. 2023;388(7):585-94.

van Werkhoven E, Hart G, van Tinteren H, Elkhuizen P, Collette L, Poortmans P, et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiotherapy and Oncology. 2011;100(1):101-7.

Whelan TJ, Smith S, Nielsen TO, Parpia S, Fyles AW, Bane A, et al. LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC). American Society of Clinical Oncology; 2022.